Vaccine News and Research

Latest Vaccine News and Research

De-worming drug praziquantel could help reduce spread of HIV in Africa

Providing girls in rural Africa with a deworming drug could help reduce the spread of HIV, according to a study recently published in PLoS Neglected Tropical Diseases, the New York Times reports.

26 May 2009

More funding urged for yellow fever vaccine stockpile

The International Coordinating Group (ICG) on Yellow Fever Vaccine Provision is warning that the global emergency stockpile of yellow fever vaccine for the world's most vulnerable populations in Africa is under threat.

26 May 2009

ImmunoVaccine Technologies partners with FIT Biotech to advance therapeutic HIV vaccine

ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based , clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU MultiHIV DNA plasmid with IVT's DepoVax vaccine delivery system to advance a therapeutic HIV vaccine.

26 May 2009

Unvaccinated children 23 times more likely to get infected with whooping cough

Children of parents who refuse vaccines are 23 times more likely to get whooping cough compared to fully immunized children, according to a new study led by a vaccine research team at Kaiser Permanente Colorado's Institute for Health Research.

26 May 2009

Sanofi Pasteur receives U.S. Government order to produce new influenza A(H1N1) vaccine

Sanofi Pasteur announced today it has received the first of what is expected to be a series of orders from the U.S. Department of Health and Human Services (HHS) to commence production of a vaccine to help protect against the new influenza A(H1N1) virus.

25 May 2009

Researchers unlock mystery of potentially fatal reaction to smallpox vaccine

Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the smallpox vaccine.

25 May 2009

HHS directs $1 billion towards commercial-scale production of a candidate vaccine for H1N1

HHS Secretary Kathleen Sebelius has announced that the department will take important steps necessary to prepare for potential commercial-scale production of a candidate vaccine for the novel Influenza A ( H1N1).

24 May 2009

Scientists map sequence mutations of the 2009 H1N1 influenza A virus

In just two weeks from the time the first patient virus samples were made available, Singapore scientists report an evolutionary analysis of a critical protein produced by the 2009 H1N1 influenza A virus strain.

22 May 2009

Vaginal ring could protect against HIV

A researcher with Weill Cornell Medical College has developed a vaginal ring that releases microbicides and could prevent HIV and unplanned pregnancies, ANI/Times of India reports.

22 May 2009

62nd World Health Assembly closes with resolutions on public health

The 62nd World Health Assembly, which brought together health ministers and senior health officials from WHO's Member States, closed today with the adoption of resolutions on a variety of global health issues including primary health care, the prevention and control of multidrug- resistant and extensively drug-resistant tuberculosis, public health, innovation and intellectual property and pandemic influenza preparedness. The Health Assembly also passed the Programme Budget for 2010 -2011.

22 May 2009

Tamed virus wipes out cancer safely

Cancer Research UK scientists have tamed a virus so that it attacks and destroys cancer cells but does not harm healthy cells, according to a paper published in PLoS Pathogens, today.

22 May 2009

Call for vaccination against HPV 16 in young men and women to prevent head and neck cancers

Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV 16 to prevent head & neck cancers.

22 May 2009

HER2/neu protein predicts development of invasive breast cancer in women with ductal carcinoma in situ

Women with ductal carcinoma in situ (DCIS) who exhibit an overexpression of the protein HER2/neu have a six-fold increase in risk of invasive breast cancer, according to a new study from the University of Pennsylvania School of Medicine.

22 May 2009

Elton John calls for increased HIV/AIDS education, care

Singer Elton John on Tuesday at the 2009 Bio International Convention in Atlanta called for renewed efforts to fight HIV/AIDS, the Atlanta Journal-Constitution reports.

22 May 2009

Methylene blue in combo with new malaria drugs curbs the spread of malaria parasites

New combinations of agents based on the oldest synthetic malaria drug, the methylene blue stain, can curb the spread of malaria parasites and make a significant contribution to the long-term eradication called for by the international "Roll Back Malaria Initiative."

20 May 2009

HIV/AIDS Vaccine Coalition urges continued funding for research amid economic crisis

A recently released AIDS Vaccine Advocacy Coalition report says that although there has been a renewed focus on discovery, innovation and basic science in vaccine research, action is needed to ensure that research funding continues during the economic downturn, VOA News reports.

20 May 2009

Algae may the key to SARS vaccine

A protein from algae may have what it takes to stop Severe Acute Respiratory Syndrome (SARS) infections, according to new research.

20 May 2009

NIH to develop therapeutics for rare and neglected diseases

The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.

20 May 2009

Recommendations by experts to WHO on influenza A (H1N1) vaccines

Current epidemiological information suggests that the influenza A (H1N1) virus transmissibility potential is at least comparable to that of seasonal influenza viruses, with ability to sustain community spread. There is therefore no reason to expect that ongoing spread of the virus will stop.

19 May 2009

Experts warn of dangers of swine flu with almost 10,000 now infected, forecasts 4.9 billion doses needed

The latest figures from the World Health Organisation (WHO) has the worldwide influenza A H1N1 (swine flu) tally fast approaching 10,000 human cases.

19 May 2009

Vaccine News and Research

Latest Vaccine News and Research

De-worming drug praziquantel could help reduce spread of HIV in Africa

More funding urged for yellow fever vaccine stockpile

ImmunoVaccine Technologies partners with FIT Biotech to advance therapeutic HIV vaccine

Unvaccinated children 23 times more likely to get infected with whooping cough

Sanofi Pasteur receives U.S. Government order to produce new influenza A(H1N1) vaccine

Researchers unlock mystery of potentially fatal reaction to smallpox vaccine

HHS directs $1 billion towards commercial-scale production of a candidate vaccine for H1N1

Scientists map sequence mutations of the 2009 H1N1 influenza A virus

Vaginal ring could protect against HIV

62nd World Health Assembly closes with resolutions on public health

Tamed virus wipes out cancer safely

Call for vaccination against HPV 16 in young men and women to prevent head and neck cancers

HER2/neu protein predicts development of invasive breast cancer in women with ductal carcinoma in situ

Elton John calls for increased HIV/AIDS education, care

Methylene blue in combo with new malaria drugs curbs the spread of malaria parasites

HIV/AIDS Vaccine Coalition urges continued funding for research amid economic crisis

Algae may the key to SARS vaccine

NIH to develop therapeutics for rare and neglected diseases

Recommendations by experts to WHO on influenza A (H1N1) vaccines

Experts warn of dangers of swine flu with almost 10,000 now infected, forecasts 4.9 billion doses needed

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in